| 000 | 01832 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515113827.0 | ||
| 264 | 0 | _c20080513 | |
| 008 | 200805s 0 0 eng d | ||
| 022 | _a1476-6256 | ||
| 024 | 7 |
_a10.1093/aje/kwn044 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrentice, Ross L | |
| 245 | 0 | 0 |
_aEstrogen plus progestin therapy and breast cancer in recently postmenopausal women. _h[electronic resource] |
| 260 |
_bAmerican journal of epidemiology _cMay 2008 |
||
| 300 |
_a1207-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBreast Neoplasms _xchemically induced |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aEstrogen Replacement Therapy _xadverse effects |
| 650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 | _aObservation |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aChlebowski, Rowan T | |
| 700 | 1 | _aStefanick, Marcia L | |
| 700 | 1 | _aManson, Joann E | |
| 700 | 1 | _aPettinger, Mary | |
| 700 | 1 | _aHendrix, Susan L | |
| 700 | 1 | _aHubbell, F Allan | |
| 700 | 1 | _aKooperberg, Charles | |
| 700 | 1 | _aKuller, Lewis H | |
| 700 | 1 | _aLane, Dorothy S | |
| 700 | 1 | _aMcTiernan, Anne | |
| 700 | 1 | _aJo O'Sullivan, Mary | |
| 700 | 1 | _aRossouw, Jacques E | |
| 700 | 1 | _aAnderson, Garnet L | |
| 773 | 0 |
_tAmerican journal of epidemiology _gvol. 167 _gno. 10 _gp. 1207-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/aje/kwn044 _zAvailable from publisher's website |
| 999 |
_c17872344 _d17872344 |
||